This is a definitive contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype testing services for cancer. The $325,998.94 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 and does not have a set-aside designation. Genomic Health provides specialized genomic-based cancer diagnostic testing services, primarily focused on its Oncotype DX portfolio of tests that analyze gene expression...
This is a $98,137.17 firm fixed-price delivery order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Genomic Health's Oncotype DX cancer diagnostic testing services, which analyze gene expression to determine cancer risk, recurrence potential, and treatment benefits. This delivery order falls under the Medical Laboratory Testing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $226,115.40 firm fixed price delivery order to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for Genomic Oncotype breast, colon, and prostate cancer testing services. This order was placed under Genomic Health's existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. Genomic Health has a history of providing cancer testing...
This contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of Oncotype genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $114,305 Blanket Purchase Agreement (BPA) call covers a performance period through February 2026 and allows the VA to order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis. Genomic Health is also the prime...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide reference lab testing services. The contract, valued at $228,525.24, was issued under the Medical Laboratory Testing and Analysis Services schedule and did not have a set-aside designation. Genomic Health has previously held multiple federal contracts with the Department of Defense and VA to deliver its...
Genomic Health, Inc. was awarded a firm fixed price blanket purchase agreement call by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 for $114,305 to provide Oncotype Genetic Testing Services from February 2024 through February 2028. The contract has no set-aside designation. Genomic Health will deliver its Oncotype DX portfolio of assays to support cancer screening, treatment selection, and disease monitoring programs at VA medical...
This is a $6,385.84 firm fixed price contract awarded by the Department of Veterans Affairs to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services at a VA medical facility in St. Louis. The contract was issued under the VA's Medical Laboratory Testing and Analysis Services master schedule contract and runs through March 2021. Genomic Health, a leading provider of genomic-based cancer diagnostic tests to the federal government, has received...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for their Oncotype DX cancer diagnostic services. The contract has a ceiling value of $3,453.96 and a period of performance through March 9, 2021. Genomic Health is a provider of genomic-based cancer testing services to federal agencies, including the VA, Department of Defense,...
This federal contract award is for the Oncotype DX laboratory test, which was awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, awarded by the Department of the Army Medical Command, has a potential value of $250,000.00 and is a firm fixed price purchase order with no set-aside designation. Genomic Health has a history of federal contracts to provide cancer testing services, including its Oncotype DX portfolio, to the Defense Health Agency, Department...